NCCN Guidelines® Insights - Breast Cancer, Version 3.2013
These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-postive metastatic breast cancer in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Breast Cancer. These include new first-line and subsequent therapy options for patients with HER2-positive metastatic breast cancer.
This activity has been designated to meet the educational needs of physicians, nurses, and pharmacists involved in the management of patients with cancer.
Upon completion of this activity, participants will be able to:
- Integrate into professional practice the updates to NCCN Guidelines for breast cancer
- Describe the rationale behind the decision-making process for developing the NCCN Guidelines for breast cancer
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician